Nimesulide tablet is a prescription anti-inflammatory drug used for treating acute (short-term) pain, painful osteoarthritis (swelling in the joints), and Primary dysmennorhea (Period Pains).
Original nimesulide was developped by Helsinn Healthcare and is marketed world-wide through a network of selected international partners.
Clinical studies have been carried out in a wide variety of acute inflammatory and painful conditions with the aim of evaluating the analgesic activity of nimesulide in comparison to placebo and to some of the most common NSAIDs.
In these studies, it is observed that the efficacy of nimesulide was consistently superior to placebo with a particularly fast onset of the analgesic in action.
The rapid action shows the immediate relief within the 15 min from the drug intake for the acute pain.
The maximum duration and dose of a treatment
course with nimesulide is 15 days, 100 mg twice a day, to minimize
the risk of hepatotoxicity.
Nimesulide should only be prescribed as second
line treatment. The decision to prescribe nimesulide should be based
on assessment of the individual patient’s overall risks.
No comments:
Post a Comment